ERBB2 and ductal breast carcinoma in situ: We also observed HER-2 positivity to be relatively common in MIBC, and when compared with pure DCIS, numerous studies have reported a higher rate of HER-2 overexpression in MIBC than in both invasive carcinomas and DCIS6,12.